Second, genetic engineering approaches enable the expression of specific receptors on these nanovesicles, facilitating active targeting of nanoparticles.[17] Bioinformatics analysis identified elevated B7H3 expression in osteosarcoma compared to normal tissues, suggesting its potential as a therapeutic target for osteosarcoma. This evidence concerns the gene CD276 and osteosarcoma.